Evidence map›Paper›PMID 39601549›Full record

ArticleAntimicrobial agents and chemotherapy2025

Efficacy and

Molly E Woodson, Holly F Walden, M Abdul Mottaleb, Maria Makri, Georgia-Myrto Prifti, Dimitrios Moianos, Vasiliki Pardali, Grigoris Zoidis, John E Tavis

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Discovery ofInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Molly E WoodsonDepartment of Molecular Microbiology and Immunology, St. Louis University School of Medicine, St. Louis, Missouri, USA.
Holly F WaldenDepartment of Molecular Microbiology and Immunology, St. Louis University School of Medicine, St. Louis, Missouri, USA.
M Abdul MottalebInstitute for Drug and Biotherapeutic Innovation, St. Louis University, St. Louis, Missouri, USA.
Maria MakriDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece.
Georgia-Myrto PriftiDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece.
Dimitrios MoianosDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece.
Vasiliki PardaliDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece.
Grigoris ZoidisDivision of Pharmaceutical Chemistry, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens, Greece.ORCID 0000-0002-9442-5186
John E TavisDepartment of Molecular Microbiology and Immunology, St. Louis University School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0002-8711-4240

Funding

Lead optimization of Hepatitis B Virus ribonuclease H inhibitorsR01AI150610 · NIAID · SAINT LOUIS UNIVERSITY · PI MEYERS, MARVIN J, TAVIS, JOHN E · 2021 to 2025
$3.3M
Liquid chromatography and mass spectrometry instrument systemS10OD032206 · OD · SAINT LOUIS UNIVERSITY · PI SVERDRUP, FRANCIS MICHAEL · 2022 to 2022
$250k
Gilead Sciences (Gilead) ASKLEPIOSNIAID NIH HHS R01 AI150610NIH HHS S10 OD032206
6 · The paper itself

Abstract

We previously reported

Indexed as

Antiviral AgentsHepatitis B virusPyridonesRibonuclease HHepatocytesHep G2 CellsHumansVirus ReplicationAntiviral AgentsPyridonesRibonuclease Hdrug discoveryHBVN-hydroxypyridinedionepharmacology

Identifiers

PMID39601549
PMCPMC11784145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.